Dr Reddy’s Laboratories’ net profit declined 36 per cent to ₹925 crore in the second quarter ended September 2026 on a year-on-year (y-o-y) basis. The total revenue of the Hyderabad-based company declined 1.5 per cent to ₹8,671 crore.
The results were impacted due to ₹239 crore provision towards inventory and associated costs related to Semaglutide API related impact, the company said on Friday.
Published on October 23, 2026
